BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial - Concepedia

Concepedia

Publication | Closed Access

BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

501

Citations

23

References

2020

Year

Bruno Bockorny, Valerya Semenisty, Teresa Macarulla, Erkut Borazanci, Brian M. Wolpin, Salomon M. Stemmer, Talia Golan, Ravit Geva, Mitesh J. Borad, Katrina S. Pedersen,

Nature Medicine

Cxcr4 AntagonistOncologyPancreatic CancerGastrointestinal OncologyMedicineCombat TrialImmunologyImmune Checkpoint InhibitorPharmacotherapyImmunotherapyPharmacology

References

	Year	Citations

Page 1

Page 1